Ratings
0
Nobody has rated this yet. Be the first!
Works
4
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
An immunogenic personal neoantigen vaccine for patients with melanoma
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
